Johnson & Johnson (JNJ) shares gain as Q4 earnings and guidance beats

Go back to Johnson & Johnson (JNJ) shares gain as Q4 earnings and guidance beats

Johnson & Johnson (JNJ) Tops Q4 EPS by 11c, Revenues Misses; Guides EPS Above Views

January 24, 2023 6:26 AM EST

Johnson & Johnson (NYSE: JNJ) reported Q4 EPS of $2.35, $0.11 better than the analyst estimate of $2.24. Revenue for the quarter came in at $23.7 billion versus the consensus estimate of $23.9 billion.

GUIDANCE:

Johnson & Johnson sees FY2023 EPS of $10.50, versus the consensus of... More